460940.Kq

The company maintains a strong liquidity position, with a current ratio of 38.76, indicating a substantial buffer of current assets over current liabilities. Its price-to-book ratio of 2.42 and price-to-tangible-book ratio of 2.42 suggest that the market values the company at a premium relative to its book value. The company's debt-to-equity ratio of 0.02 indicates a low level of leverage, which contributes to its strong liquidity profile.

In terms of profitability, the company's return on equity of 6.36% and return on assets of 6.1% are indicators of its efficiency in generating returns from its equity and asset base. These metrics are in line with the industry's preferred metrics, which emphasize operational efficiency and asset utilization. The company's operating income of 1,002,406,500 KRW and net income of 2,749,973,250 KRW reflect its ability to maintain profitability despite the capital-intensive nature of the healthcare equipment and supplies industry.

The company's revenue is primarily concentrated in the healthcare services and equipment segment, with no significant geographic diversification disclosed in the available data. This concentration may expose the company to specific market risks, although the data does not provide a detailed breakdown of geographic exposure.

The company's growth trajectory is supported by its free cash flow of 860,355,970 KRW, which provides flexibility for reinvestment or shareholder returns. The company's capital expenditure of -1,799,970,280 KRW indicates a significant investment in long-term assets, which is consistent with the capital-intensive nature of the industry. The company's operating cash flow of -1,581,900,170 KRW suggests that it is currently investing more in operations than it is generating, which may be a temporary phase as it expands its asset base.

The company's risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high current ratio contribute to its strong liquidity position. The absence of dilution risk is further supported by the fact that the number of shares outstanding has not changed between the basic and diluted counts.

Recent events, as reflected in the financial data, show that the company has maintained a consistent revenue and earnings performance, with the last actual EPS of 206.73 KRW and revenue of 7,639,480,000 KRW. The company's market price of 7,900 KRW and market cap of 104,718,292,000 KRW indicate a strong investor confidence in its future prospects.